- Home
- VTOL vs CVAC Comparison
VTOL vs CVAC Comparison
Compare VTOL & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTOL
- CVAC
- Stock Information
- Founded
- VTOL N/A
- CVAC 2000
- Country
- VTOL United States
- CVAC Germany
- Employees
- VTOL N/A
- CVAC N/A
- Industry
- VTOL Transportation Services
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- VTOL Consumer Discretionary
- CVAC Health Care
- Exchange
- VTOL Nasdaq
- CVAC Nasdaq
- Market Cap
- VTOL 1.1B
- CVAC 1.2B
- IPO Year
- VTOL N/A
- CVAC 2020
- Fundamental
- Price
- VTOL $39.07
- CVAC $5.38
- Analyst Decision
- VTOL
- CVAC Hold
- Analyst Count
- VTOL 0
- CVAC 3
- Target Price
- VTOL N/A
- CVAC $6.83
- AVG Volume (30 Days)
- VTOL 149.4K
- CVAC 422.9K
- Earning Date
- VTOL 11-04-2025
- CVAC 11-12-2025
- Dividend Yield
- VTOL N/A
- CVAC N/A
- EPS Growth
- VTOL 268.18
- CVAC N/A
- EPS
- VTOL 3.99
- CVAC 1.01
- Revenue
- VTOL $1,445,607,000.00
- CVAC $599,540,810.00
- Revenue This Year
- VTOL $10.00
- CVAC N/A
- Revenue Next Year
- VTOL $8.48
- CVAC $23.40
- P/E Ratio
- VTOL $9.63
- CVAC $5.35
- Revenue Growth
- VTOL 4.01
- CVAC 675.15
- 52 Week Low
- VTOL $25.11
- CVAC $2.37
- 52 Week High
- VTOL $42.06
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- VTOL 54.57
- CVAC 49.44
- Support Level
- VTOL $38.05
- CVAC $5.35
- Resistance Level
- VTOL $42.06
- CVAC $5.41
- Average True Range (ATR)
- VTOL 1.15
- CVAC 0.04
- MACD
- VTOL 0.05
- CVAC -0.00
- Stochastic Oscillator
- VTOL 42.76
- CVAC 50.00
About VTOL Bristow Group Inc.
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers in Australia, Brazil, Canada, Chile, the Dutch Caribbean, the Falkland Islands, India, Ireland, the Kingdom of Saudi Arabia, Mexico, the Netherlands, Nigeria, Norway, Spain, Suriname, Trinidad, the UK, and the U.S. offshore energy customers use services to transport personnel to, from and between offshore energy installations.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.